» Articles » PMID: 29206988

Group-Based Trajectory of Body Shape From Ages 5 to 55 Years and Cardiometabolic Disease Risk in 2 US Cohorts

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2017 Dec 6
PMID 29206988
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The association of adiposity across the life span with cardiometabolic risk is not completely delineated. We used a group-based modeling approach to identify distinct trajectories of body shape from ages 5 years to 55 years among 84,792 women from the Nurses' Health Study (1976-2010) and 37,706 men from the Health Professionals Follow-up Study (1986-2010) and assessed the associations between these trajectories and incidence of type 2 diabetes and cardiovascular disease (CVD) during a 17-year follow-up period. Compared with those who maintained leanness throughout the life span ("lean-stable" trajectory), participants who maintained a medium body shape ("medium-stable" trajectory) had somewhat increased risk. Those who started lean but had a moderate or marked increase in adiposity ("lean-moderate increase" and "lean-marked increase" trajectories) had even higher risk (e.g., for a "lean-marked increase" trajectory, the hazard ratio for diabetes was 8.11 (95% confidence interval (95% CI): 7.10, 9.27) in women and 2.36 (95% CI: 2.04, 2.74) in men; for CVD, it was 1.38 (95% CI: 1.25, 1.52) in women and 1.28 (95% CI: 1.16, 1.41) in men). Participants who started heavy and became heavier (a "heavy-increase" trajectory) had substantially elevated risk (for diabetes, the hazard ratio was 7.34 (95% CI: 6.40, 8.42) in women and 2.80 (95% CI: 2.37, 3.31) in men; for CVD, it was 1.55 (95% CI: 1.40, 1.71) in women and 1.35 (95% CI: 1.20, 1.53) in men). Our data showed that trajectories of body shape from ages 5 to 55 years were associated with subsequent risk of developing type 2 diabetes and CVD.

Citing Articles

Association of childhood-adulthood body size trajectories with risk of micro- and macrovascular complications among individuals with type 2 diabetes: a prospective study.

Zeng X, Lian X, Wang Y, Shang X, Yu H Diabetol Metab Syndr. 2024; 16(1):289.

PMID: 39609926 PMC: 11605916. DOI: 10.1186/s13098-024-01499-2.


Association of longitudinal trajectories of fasting plasma glucose with all-cause and cardiovascular mortality among a Chinese older population: a retrospective cohort study.

Chen X, Ding J, Shi Z, Bai K, Shi S, Tian Q BMC Public Health. 2024; 24(1):1335.

PMID: 38760762 PMC: 11102116. DOI: 10.1186/s12889-024-18823-0.


The association of long-term trajectories of BMI, its variability, and metabolic syndrome: a 30-year prospective cohort study.

Guo T, Zheng S, Chen T, Chu C, Ren J, Sun Y EClinicalMedicine. 2024; 69:102486.

PMID: 38370536 PMC: 10874716. DOI: 10.1016/j.eclinm.2024.102486.


Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease.

Carrasquilla G, Angquist L, Sorensen T, Kilpelainen T, Loos R Diabetologia. 2023; 67(5):864-873.

PMID: 38085289 PMC: 10954919. DOI: 10.1007/s00125-023-06058-4.


Diet strategies for promoting healthy aging and longevity: An epidemiological perspective.

Hu F J Intern Med. 2023; 295(4):508-531.

PMID: 37867396 PMC: 10939982. DOI: 10.1111/joim.13728.


References
1.
McGee D . Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol. 2005; 15(2):87-97. DOI: 10.1016/j.annepidem.2004.05.012. View

2.
Charakida M, Khan T, Johnson W, Finer N, Woodside J, Whincup P . Lifelong patterns of BMI and cardiovascular phenotype in individuals aged 60-64 years in the 1946 British birth cohort study: an epidemiological study. Lancet Diabetes Endocrinol. 2014; 2(8):648-54. DOI: 10.1016/S2213-8587(14)70103-2. View

3.
Preston S, Mehta N, Stokes A . Modeling obesity histories in cohort analyses of health and mortality. Epidemiology. 2012; 24(1):158-66. PMC: 3870658. DOI: 10.1097/EDE.0b013e3182770217. View

4.
Araujo J, Severo M, Barros H, Mishra G, Guimaraes J, Ramos E . Developmental trajectories of adiposity from birth until early adulthood and association with cardiometabolic risk factors. Int J Obes (Lond). 2015; 39(10):1443-9. DOI: 10.1038/ijo.2015.128. View

5.
Sattar N . Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Pract Res Clin Endocrinol Metab. 2013; 27(4):501-7. DOI: 10.1016/j.beem.2013.05.006. View